RYR1 and Malignant hyperthermia: Moreover, RYR1 variants can cause malignant hyperthermia (MH) susceptibility, a hypermetabolic response characterized by chronic muscle contraction and elevated body temperature in response to halogenated anesthetics [14, 15].